STE Quote, Financials, Valuation and Earnings

Nutriband has a net margin of 11.29% compared to Steris PLC's net margin of -211%. Steris PLC's return on equity of 6.81% beat Nutriband's return on equity of -69.58%.

Steris PLC has a consensus price target of $249.39, signalling upside risk potential of 22.24%. On the other hand Nutriband has an analysts' consensus of -- which suggests that it could grow by 255.03%. Given that Nutriband has higher upside potential than Steris PLC, analysts believe Nutriband is more attractive than Steris PLC.

Steris PLC has a beta of 0.838, which suggesting that the stock is 16.181% less volatile than S&P 500. In comparison Nutriband has a beta of 0.396, suggesting its less volatile than the S&P 500 by 60.406%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1.07%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 53.03% of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.3B, which are larger than Nutriband quarterly revenues of $645.8K. Steris PLC's net income of $150M is higher than Nutriband's net income of -$1.4M. Notably, Steris PLC's price-to-earnings ratio is 46.60x while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 3.96x versus 24.85x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

enVVeno Medical has a net margin of 11.29% compared to Steris PLC's net margin of --. Steris PLC's return on equity of 6.81% beat enVVeno Medical's return on equity of --.

Steris PLC has a consensus price target of $249.39, signalling upside risk potential of 22.24%. On the other hand enVVeno Medical has an analysts' consensus of -- which suggests that it could grow by 435.71%. Given that enVVeno Medical has higher upside potential than Steris PLC, analysts believe enVVeno Medical is more attractive than Steris PLC.

Steris PLC has a beta of 0.838, which suggesting that the stock is 16.181% less volatile than S&P 500. In comparison enVVeno Medical has a beta of 1.206, suggesting its more volatile than the S&P 500 by 20.612%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1.07%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 53.03% of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.3B, which are larger than enVVeno Medical quarterly revenues of --. Steris PLC's net income of $150M is higher than enVVeno Medical's net income of -$5.6M. Notably, Steris PLC's price-to-earnings ratio is 46.60x while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 3.96x versus 286.56x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

SINTX Technologies has a net margin of 11.29% compared to Steris PLC's net margin of -1700%. Steris PLC's return on equity of 6.81% beat SINTX Technologies's return on equity of -132.95%.

Steris PLC has a consensus price target of $249.39, signalling upside risk potential of 22.24%. On the other hand SINTX Technologies has an analysts' consensus of $300.00 which suggests that it could grow by 1797.02%. Given that SINTX Technologies has higher upside potential than Steris PLC, analysts believe SINTX Technologies is more attractive than Steris PLC.

Steris PLC has a beta of 0.838, which suggesting that the stock is 16.181% less volatile than S&P 500. In comparison SINTX Technologies has a beta of 1.492, suggesting its more volatile than the S&P 500 by 49.157%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1.07%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 53.03% of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.3B, which are larger than SINTX Technologies quarterly revenues of $367K. Steris PLC's net income of $150M is higher than SINTX Technologies's net income of -$6.2M. Notably, Steris PLC's price-to-earnings ratio is 46.60x while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 3.96x versus 1.01x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Beyond Air has a net margin of 11.29% compared to Steris PLC's net margin of -1673.94%. Steris PLC's return on equity of 6.81% beat Beyond Air's return on equity of -219.34%.

Steris PLC has a consensus price target of $249.39, signalling upside risk potential of 22.24%. On the other hand Beyond Air has an analysts' consensus of $2.50 which suggests that it could grow by 594.44%. Given that Beyond Air has higher upside potential than Steris PLC, analysts believe Beyond Air is more attractive than Steris PLC.

Steris PLC has a beta of 0.838, which suggesting that the stock is 16.181% less volatile than S&P 500. In comparison Beyond Air has a beta of -0.167, suggesting its less volatile than the S&P 500 by 116.653%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 1.07%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 53.03% of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.3B, which are larger than Beyond Air quarterly revenues of $798K. Steris PLC's net income of $150M is higher than Beyond Air's net income of -$13.4M. Notably, Steris PLC's price-to-earnings ratio is 46.60x while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 3.96x versus 6.24x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.